When G6PD testing is not available, it is frequently decided not to prescribe the drugs, despite their effectiveness in killing hypnozoites and preventing relapse, causing a significant burden for vivax malaria eradication. This evidence concerns the gene G6PD and Plasmodium vivax malaria.